Referral of Patients to Hepatology With Hepatoscope
Recruiting
N/A
Interventional Study
Chronic Liver Disease
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 80
- Sex
- Any
- Study type
- Interventional
- Purpose
- Screening
- Participants needed
- 200 (estimated)
- Sponsor
- University Hospital, Antwerp · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Patients identified as being at risk of liver fibrosis because of a positive Fibrosis-4 (FIB-4) test in the primary care setting will be offered be enrolled in the trial and to undergo an Hepatoscope exam (external non-invasive ultrasound imaging exam) to screen for liver fibrosis (with stiffness measurements) and/or steatosis (with ultrasound parameters related to fatty liver). All patients prese…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients with any of the following
* Elevated liver enzymes (AST, ALT, Gamma-GT, AP)
* Type 2 diabetes
* Elements of metabolic syndrome
* Patients who consent in written to participate in the Clinical Investigation after being orally informed on the objectives and metho…
Contacts
No contact information available.